BBC
Virtus Biotech Clinical Trials ETF
BBC
Virtus Biotech Clinical Trials ETF
$ 46.7
-
This exchange-traded fund (ETF) endeavors to match the capital appreciation and income generation of the LifeSci Biotechnology Clinical Trials Index, disregarding fees and expenses. The underlying index focuses on tracking the financial progress of a carefully chosen group of biotechnology firms engaged in clinical trials. It is important to note that, as of February 27, the fund's official name transitioned from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
| Ticker | Company | Weight |
|---|---|---|
| ERAS | Erasca Inc | 2.98% |
| ALMS | Alumis Inc | 1.70% |
| BCTG | BCTG Acquisition Corp | 1.46% |
| DNTH | Dianthus Therapeutics Inc. | 1.45% |
| CRVS | Corvus Pharmaceuticals Inc | 1.44% |
| TECX | Tectonic Therapeutic, Inc. | 1.33% |
| ELVN | Enliven Therapeutics Inc. | 1.30% |
| TYRA_old | TYRA | 1.26% |
| ACLX | Arcellx Inc | 1.25% |
| ALLO | Allogene Therapeutics Inc | 1.25% |
| Asset | Price | Div. Yield |
|---|